Close Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.9M | Sell |
38,989
-15,991
| -29% | -$16.2M | 0.97% | 27 |
|
|
2025
Q4 | $59.1M | Sell |
54,980
-2,127
| -4% | -$2.03M | 1.31% | 20 |
|
|
2025
Q3 | $43.5M | Sell |
57,107
-1,850
| -3% | -$1.38M | 0.97% | 26 |
|
|
2025
Q2 | $45.9M | Sell |
58,957
-9
| -0% | -$6.99K | 1.34% | 24 |
|
|
2025
Q1 | $48.7M | Buy |
58,966
+17,586
| +42% | +$14.6M | 1.4% | 23 |
|
|
2024
Q4 | $32M | Hold |
41,380
| – | – | 0.9% | 26 |
|
|
2024
Q3 | $36.6M | Buy |
41,380
+4,144
| +11% | +$3.73M | 1.13% | 25 |
|
|
2024
Q2 | $33.7M | Buy |
37,236
+12,958
| +53% | +$10.4M | 1.15% | 24 |
|
|
2024
Q1 | $18.9M | Buy |
24,278
+6,054
| +33% | +$4.31M | 0.69% | 30 |
|
|
2023
Q4 | $10.6M | Buy |
18,224
+12,722
| +231% | +$7.43M | 0.44% | 37 |
|
|
2023
Q3 | $2.96M | Buy |
5,502
+1,099
| +25% | +$566K | 0.15% | 56 |
|
|
2023
Q2 | $2.06M | Buy |
4,403
+1,597
| +57% | +$670K | 0.1% | 60 |
|
|
2023
Q1 | $963K | Buy |
2,806
+368
| +15% | +$124K | 0.05% | 68 |
|
|
2022
Q4 | $892K | Buy |
2,438
+4
| +0.2% | +$1.42K | 0.05% | 63 |
|
|
2022
Q3 | $788K | Sell |
2,434
-130
| -5% | -$41.2K | 0.04% | 63 |
|
|
2022
Q2 | $832K | Buy |
2,564
+515
| +25% | +$155K | 0.04% | 66 |
|
|
2022
Q1 | $566K | Hold |
2,049
| – | – | 0.02% | 67 |
|
|
2021
Q4 | $566K | Sell |
2,049
-190
| -8% | -$48.2K | 0.02% | 67 |
|
|
2021
Q3 | $517K | Sell |
2,239
-103
| -4% | -$25.4K | 0.03% | 68 |
|
|
2021
Q2 | $537K | Sell |
2,342
-151
| -6% | -$30.3K | 0.03% | 75 |
|
|
2021
Q1 | $466K | Hold |
2,493
| – | – | 0.02% | 81 |
|
|
2020
Q4 | $421K | Hold |
2,493
| – | – | 0.03% | 64 |
|
|
2020
Q3 | $369K | Hold |
2,493
| – | – | 0.03% | 68 |
|
|
2020
Q2 | $409K | Sell |
2,493
-119
| -5% | -$18.3K | 0.03% | 66 |
|
|
2020
Q1 | $362K | Sell |
2,612
-150
| -5% | -$20.6K | 0.03% | 67 |
|
|
2019
Q4 | $363K | Buy |
2,762
+52
| +2% | +$6.03K | 0.03% | 71 |
|
|
2019
Q3 | $303K | Hold |
2,710
| – | – | 0.03% | 78 |
|
|
2019
Q2 | $300K | Buy |
2,710
+768
| +40% | +$90.4K | 0.02% | 78 |
|
|
2019
Q1 | $252K | Sell |
1,942
-22,489
| -92% | -$2.73M | 0.02% | 89 |
|
|
2018
Q4 | $1.1M | Buy |
24,431
+22,489
| +1,158% | +$2.51M | 0.12% | 53 |
|
|
2018
Q3 | $208K | Buy |
1,942
+1,392
| +253% | +$139K | 0.02% | 95 |
|
|
2018
Q2 | $42K | Hold |
550
| – | – | ﹤0.01% | 131 |
|
|
2018
Q1 | $42K | Sell |
550
-25
| -4% | -$2.01K | ﹤0.01% | 135 |
|
|
2017
Q4 | $49K | Hold |
575
| – | – | ﹤0.01% | 127 |
|
|
2017
Q3 | $49K | Hold |
575
| – | – | ﹤0.01% | 126 |
|
|
2017
Q2 | $47K | Sell |
575
-140
| -20% | -$11.4K | 0.01% | 133 |
|
|
2017
Q1 | $60K | Sell |
715
-297
| -29% | -$23.8K | 0.01% | 120 |
|
|
2016
Q4 | $74K | Buy |
+1,012
| New | +$75.4K | 0.01% | 91 |
|
Other funds holding LLY
VCM
VPM
Close Asset Management's LLY Position: Q1 2026 in Review
Close Asset Management reduced its Eli Lilly (LLY) stake by 29% in Q1 2026, selling an estimated $16.2M and leaving 38,989 shares worth $35.9M. The position accounts for 0.97% of the portfolio, ranked #27.
Close Asset Management first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $59.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Close Asset Management held 38,989 shares of Eli Lilly worth $35.9M as of Q1 2026.
- Close Asset Management sold 15,991 Eli Lilly shares in Q1 2026, an estimated $16.2M.
- Eli Lilly made up 0.97% of Close Asset Management's portfolio in Q1 2026, its #27 holding.
- Close Asset Management first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
- Close Asset Management's Eli Lilly position peaked at $59.1M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.